Safe as mother's milk: carbohydrates as future anti-adhesion drugs for bacterial diseases.
about
In vitro and in vivo effects of soluble, monovalent globotriose on bacterial attachment and colonizationHigh-throughput mass finger printing and Lewis blood group assignment of human milk oligosaccharides.In-vitro antimicrobial, antibiofilm, cytotoxic, antifeedant and larvicidal properties of novel quinone isolated from Aegle marmelos (Linn.) CorreaA glycobiology review: carbohydrates, lectins and implications in cancer therapeuticsStreptococcus pyogenes glycoprotein-binding strepadhesin activity is mediated by a surface-associated carbohydrate-degrading enzyme, pullulanase.Fighting infectious diseases with inhibitors of microbial adhesion to host tissues.Analysis and validation of carbohydrate three-dimensional structures.Inhibitory effect of cranberry juice on the colonization of Streptococci species: An in vitro studyBacterial Adhesion of Streptococcus suis to Host Cells and Its Inhibition by Carbohydrate Ligands.Prebiotic galactooligosaccharides reduce adherence of enteropathogenic Escherichia coli to tissue culture cellsFluorescence polarization assays in small molecule screening.Targeting the bacteria-host interface: strategies in anti-adhesion therapy.Temporal Change of the Content of 10 Oligosaccharides in the Milk of Chinese Urban MothersPlant cell wall polysaccharides as potential resources for the development of novel prebioticsLectin staining patterns in human gastric mucosae with and without exposure to Helicobacter pylori.Microelectrode array biosensor for studying carbohydrate-mediated interactions.Specific labeling of peptidoglycan precursors as a tool for bacterial cell wall studies.Glycosylation of the major polar tube protein of Encephalitozoon hellem, a microsporidian parasite that infects humans.Production of chitooligosaccharides and their potential applications in medicineCapability of yeast derivatives to adhere enteropathogenic bacteria and to modulate cells of the innate immune system.Bioactive substances from marine fishes, shrimps, and algae and their functions: present and future.Adherence inhibition of Cronobacter sakazakii to intestinal epithelial cells by lactoferrin.Structural basis for the interaction between human milk oligosaccharides and the bacterial lectin PA-IIL of Pseudomonas aeruginosa.Identification of a novel streptococcal adhesin P (SadP) protein recognizing galactosyl-α1-4-galactose-containing glycoconjugates: convergent evolution of bacterial pathogens to binding of the same host receptor.Antiadhesive properties of arabinogalactan protein from ribes nigrum seeds against bacterial adhesion of Helicobacter pylori.Adherence inhibition of Cronobacter sakazakii to intestinal epithelial cells by prebiotic oligosaccharides.Oligosaccharide-mediated inhibition of the adhesion of pathogenic Escherichia coli strains to human gut epithelial cells in vitro.Bacillus subtilis and yeast cell wall improve the intestinal health of broilers challenged by Clostridium perfringens.Levorotatory carbohydrates and xylitol subdue Streptococcus mutans and Candida albicans adhesion and biofilm formation.Synthesis and application of glycoconjugate-functionalized magnetic nanoparticles as potent anti-adhesion agents for reducing enterotoxigenic Escherichia coli infections.Quantitative evaluation of E. coli F4 and Salmonella Typhimurium binding capacity of yeast derivatives.Effect of xylitol on adhesion of Salmonella Typhimurium and Escherichia coli O157:H7 to beef carcass surfaces.Secretory IgA N- and O-glycans provide a link between the innate and adaptive immune systems.Treatment of Helicobacter pylori infection using a novel antiadhesion compound (3'sialyllactose sodium salt). A double blind, placebo-controlled clinical study.Glycomacropeptide Reduces Intestinal Epithelial Cell Barrier Dysfunction and Adhesion of Entero-Hemorrhagic and Entero-Pathogenic Escherichia coli in Vitro.Improved in vitro assay for determining the mucin adherence of bacteria sensitive to Triton X-100 treatment.Anaphylactic reaction to galactose-derived oligosaccharide residues from lactose used as a drug excipient.Addressing the global need to combat multidrug resistance: carbohydrates may hold the key.Mannosylated N-aryl substituted 3-hydroxypyridine-4-ones: synthesis, hemagglutination inhibitory properties, and molecular modeling.Human milk oligosaccharides inhibit the adhesion to Caco-2 cells of diarrheal pathogens: Escherichia coli, Vibrio cholerae, and Salmonella fyris.
P2860
Q33935436-841533F9-A5A5-4F4D-A66D-FB752E4088F6Q34012948-A0552FD4-E7B0-4A2A-9E43-4E1DDACD64F0Q34438893-A03E4B86-F981-46AC-9FE2-92293FFDA6DBQ34524965-04E416FA-463A-4558-A9DB-C63086642DC6Q34581867-F8A47453-60C7-43F9-BD09-1F4436CA4477Q34680458-A027CA09-2251-4D10-80DA-31690A3AE0D2Q34930770-22C1FBA8-2942-4F74-B59F-2B2F9A64B2B9Q35098505-65ADDD8E-B1F4-44E7-AF0B-23E187E69965Q35169600-BEE12E8A-A394-4F76-8597-D30B5CB2836CQ35220308-78E2F57C-0DEB-4711-8C18-7C602FF4CB4EQ35750597-1C4E1433-9DF0-4025-B78F-558B32653DD6Q37009022-CD0F1BB8-A4CE-4456-B405-5AEBAC12F861Q37045127-B3FB25B7-0A50-4205-9C4F-CA45BC8C31EEQ37145360-D0E9C314-9725-4E66-AFFC-EB57AC617850Q37159145-4A52A0ED-5E58-409F-BCB5-9B4FDF6DA683Q37321043-29F67FB1-4DC9-42E8-8C0E-EF488102E8BFQ37378671-7E9E3759-AFCA-4CCB-BAA9-5D6770CEEF63Q37582876-1EEA2419-4C11-4A6B-BBCA-092BD87C5167Q37766095-488ABA34-CE37-4EB9-9485-BD31D5C3B2D3Q38012063-4B1624FA-D645-4184-8DCE-22161B777083Q38219133-E0AB22FF-A10B-4DAD-8F76-B20F44AD3755Q38306400-19F8090F-3BEF-4C18-98A5-B719DE645BC4Q38328871-99C47795-EA45-45C2-B4F7-7F8499EC735FQ38331987-1A41D505-808C-4864-B454-5CA9DE303C94Q39012398-02B052C4-86D8-494D-AB8F-20635DAD1029Q39598001-C27A8B4B-6047-46CD-92E3-25D77F444F16Q39910611-D75E2865-D697-4514-A2CB-1C1E1F5BF8F4Q40079718-706EAD6C-4D09-464C-8AD8-654BDFAC10A8Q40443595-61CD4B02-3432-4218-A986-C7455403DE4BQ41303130-20F3BE7D-DBEF-4BF2-97AA-FDF1F0957E0CQ42087827-34B854FD-2C92-4DC7-B476-88FD1E555C19Q43358814-61794F03-E328-44FC-9374-91F2B00B6BEDQ44362265-3506B2D7-1211-48CE-9C44-474FB2864A10Q44570116-E85352ED-6B36-410C-8510-C7EEE3F4C012Q46273400-7892AF03-D2F9-4383-8200-1B23FF387E22Q46769558-CDC0BAF0-9EB4-4A09-A63E-D1774BA3F838Q48191757-02B76EB5-CFD5-4EE0-B30F-16DA4158F182Q48723015-6203EE69-7525-4438-BD65-5A1361123518Q50052231-BD7809AD-DC36-4D26-B393-1CCCA1D2559EQ50083560-60B54868-77AD-4F2F-B7DB-3E9C966CE625
P2860
Safe as mother's milk: carbohydrates as future anti-adhesion drugs for bacterial diseases.
description
2000 nî lūn-bûn
@nan
2000 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Safe as mother's milk: carbohy ...... drugs for bacterial diseases.
@ast
Safe as mother's milk: carbohy ...... drugs for bacterial diseases.
@en
Safe as mother's milk: carbohy ...... drugs for bacterial diseases.
@nl
type
label
Safe as mother's milk: carbohy ...... drugs for bacterial diseases.
@ast
Safe as mother's milk: carbohy ...... drugs for bacterial diseases.
@en
Safe as mother's milk: carbohy ...... drugs for bacterial diseases.
@nl
prefLabel
Safe as mother's milk: carbohy ...... drugs for bacterial diseases.
@ast
Safe as mother's milk: carbohy ...... drugs for bacterial diseases.
@en
Safe as mother's milk: carbohy ...... drugs for bacterial diseases.
@nl
P356
P1476
Safe as mother's milk: carbohy ...... drugs for bacterial diseases.
@en
P2888
P304
P356
10.1023/A:1011091029973
P577
2000-07-01T00:00:00Z
P5875
P6179
1026094820